Sigma Healthcare Limited (ASX:SIG)
Australia flag Australia · Delayed Price · Currency is AUD
2.670
-0.010 (-0.37%)
Sep 9, 2026, 4:10 PM AEST

Sigma Healthcare Stock Forecast

Stock Price Forecast

According to 16 analysts polled by S&P Global, Sigma Healthcare stock has a consensus rating of "Buy" and an average price target of $3.20. The average 1-year stock price forecast is 19.85% higher than the current stock price, while the lowest is $2.60 (-2.62%) and the highest is $3.80 (+42.32%).

Price Target: $3.20 (+19.85%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.60$3.20$3.20$3.80
Change-2.62%+19.85%+19.85%+42.32%

Analyst Ratings

The average analyst rating for Sigma Healthcare stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMar '26Apr '26May '26Jun '26Jul '26Aug '26
Strong Buy688889
Buy323332
Hold433445
Sell111000
Strong Sell000000
Total141415151516

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
J.P. Morgan
J.P. Morgan
Buy
Maintains
$3.20
BuyMaintains$3.20+19.85%Sep 2, 2026
Jefferies
Jefferies
Buy
Maintains
$3.20
BuyMaintains$3.20+19.85%Aug 31, 2026
Morgans
Morgans
Buy
Upgrades
$3.19
BuyUpgrades$3.19+19.48%Aug 28, 2026
Ord Minnett
Ord Minnett
Buy
Maintains
$3.40
BuyMaintains$3.40+27.34%Aug 28, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$3.20$3.30
BuyMaintains$3.20$3.30+23.60%Aug 28, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
12.20B
from 10.83B
Increased by 12.63%
Revenue Next Year
13.44B
from 12.20B
Increased by 10.15%
EPS This Year
0.08
from 0.06
Increased by 18.50%
EPS Next Year
0.09
from 0.08
Increased by 17.97%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
2.99B3.09B3.29B6.00B10.83B12.20B
Revenue Growth
23.67%3.27%6.59%82.18%80.53%12.63%
Gross Profit
1.07B917.70M1.04B1.44B1.96B2.23B
Gross Margin
35.83%29.69%31.66%24.00%18.06%18.28%
Operating Income
574.54M428.73M552.65M722.59M992.05M1.28B
Net Income
385.93M304.33M541.01M529.91M709.18M864.85M
EPS
----0.060.08
EPS Growth
----15.61%18.50%
Forward PE
---50.6837.3635.42
Dividend / Share
---0.010.040.05
Dividend Growth
----207.69%13.80%
Free Cash Flow
140.63M367.65M48.92M-216.74M390.57M723.42M
No. Analysts
-----16
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Revenue202720282029
High12.4B
Avg12.2B
Low12.0B

Revenue Growth

Revenue Growth202720282029
High
14.8%
Avg
12.6%
Low
10.7%

EPS Forecast

EPS202720282029
High0.08
Avg0.08
Low0.07

EPS Growth

EPS Growth202720282029
High
25.7%
Avg
18.5%
Low
10.0%